Core Viewpoint - Guizhou Bailing (002424) has been penalized for financial misconduct, including false disclosures in annual reports from 2019 to 2023, leading to significant fines and administrative actions against the company and its executives [1][5][10]. Group 1: Company Penalties and Financial Misconduct - The company received a notice from the China Securities Regulatory Commission (CSRC) on November 8, 2024, regarding an investigation into alleged violations of information disclosure laws [1]. - Guizhou Bailing was found to have overstated profits by 63.79 million yuan, accounting for 45.04% of the reported profit for the period, and understated sales expenses by 459.41 million yuan, which represented 93.17% of the reported profit [5]. - The Guizhou Securities Regulatory Bureau proposed a fine of 10 million yuan against Guizhou Bailing for its financial misconduct [5]. Group 2: Executive Accountability - The former chairman, Jiang Wei, was found to have neglected his responsibilities, leading to the financial misconduct, and is subject to a 500,000 yuan fine and a 10-year ban from the securities market [6]. - Other executives, including the former general manager and board secretary, received fines ranging from 60,000 to 350,000 yuan for their roles in the misconduct [7]. - Jiang Wei's actions were deemed severe enough to warrant a comprehensive investigation, as he was aware of the issues with sales expense accounting [6][7]. Group 3: Company Operations and Future Outlook - Despite the penalties, Guizhou Bailing stated that its production and business activities remain normal, and the company is committed to improving internal controls and compliance with regulations [12]. - The company's stock will be renamed "ST Bailing" starting December 23, 2025, reflecting the risk warning due to the financial misconduct [11]. - As of the third quarter of 2025, Guizhou Bailing reported a revenue of 2.102 billion yuan, a year-on-year decrease of 24.28%, and a net profit of 56.81 million yuan, down 35.60% from the previous year [14].

Core Viewpoint - Guizhou BaiLing has been penalized for financial misconduct, including false reporting in annual reports from 2019 to 2021 and 2023, leading to a significant impact on its stock trading status and management [2][3]. Group 1: Regulatory Actions - Guizhou BaiLing received an administrative penalty notice from the Guizhou Securities Regulatory Bureau due to false records in its financial reports [2]. - The company is required to correct its financial statements and has been fined 10 million yuan, while its chairman, Jiang Wei, faces a fine of 5 million yuan and a 10-year market ban [3][4]. Group 2: Financial Misconduct Details - The investigation revealed that Guizhou BaiLing understated sales expenses from 2019 to 2021, resulting in an inflated profit of 654.726 million yuan, while in 2023, it overstated sales expenses, reducing profit by 459.411 million yuan [3]. - The regulatory body emphasized a zero-tolerance policy towards financial fraud, aiming to protect investor rights and maintain market integrity [5]. Group 3: Company Performance - In the third quarter, Guizhou BaiLing reported a revenue of 640 million yuan, a year-on-year increase of 1.11%, while the net profit attributable to shareholders was 4.9798 million yuan, up 559.90% [6]. - For the first three quarters, the total revenue was 2.102 billion yuan, a decrease of 24.28%, with a net profit of 56.8144 million yuan, down 35.60% [6]. Group 4: Chairman's Background and Current Issues - Jiang Wei, the chairman, is under investigation for insider trading and other violations, which are stated to be personal matters and not affecting the company's operations [8]. - His wealth has significantly declined from over 20 billion yuan in 2015 to 3 billion yuan in 2021, reflecting a drastic drop in his financial standing [12].

Core Viewpoint - Guizhou BaiLing has been penalized for financial misconduct, including false reporting in annual reports from 2019 to 2021 and 2023, leading to a stock suspension and a change in trading status to "ST BaiLing" [1][2]. Group 1: Financial Misconduct - Guizhou BaiLing was found to have understated sales expenses from 2019 to 2021, resulting in an inflated profit of 654.726 million yuan, while in 2023, it overstated sales expenses, reducing profit by 459.411 million yuan [2]. - The company and its chairman, Jiang Wei, are facing maximum penalties, including a fine of 10 million yuan for the company and a total of 15.6 million yuan for Jiang Wei and other responsible parties, with Jiang Wei personally fined 5 million yuan and facing a 10-year market ban [2]. Group 2: Regulatory Response - The Guizhou Securities Regulatory Bureau emphasizes a zero-tolerance policy towards financial fraud, aiming to enhance regulatory effectiveness and protect investor rights [3]. - The bureau is focusing on key individuals such as controlling shareholders and executives, ensuring strict enforcement of regulations to maintain market integrity [3]. Group 3: Company Overview and Financial Performance - Guizhou BaiLing is a well-known pharmaceutical brand in China, involved in the research, production, and sales of traditional medicine and other pharmaceutical products [4]. - The company's Q3 financial report shows a revenue of 640 million yuan, a year-on-year increase of 1.11%, while the net profit attributable to shareholders was 4.9798 million yuan, up 559.90% [4]. - For the first three quarters, total revenue was 2.102 billion yuan, down 24.28%, with a net profit of 56.8144 million yuan, down 35.60% [4]. Group 4: Chairman's Background and Current Issues - Jiang Wei, the chairman of Guizhou BaiLing, is under investigation for insider trading and other violations, which is separate from the company's operational activities [6]. - Jiang Wei's wealth has significantly declined from over 20 billion yuan in 2015 to 3 billion yuan in 2021, reflecting a drastic drop in his financial standing [11][12].

Group 1 - Fuhua Dongfang (300173.SZ) received an administrative penalty notice from the Guangdong Securities Regulatory Bureau due to false disclosures in its annual report financial indicators, leading to a change in stock name to "ST Fuhua" and a risk warning [2] - The stock of Fuhua Dongfang will be suspended for one day starting December 22, 2025, and will resume trading on December 23, 2025 [2] - Guizhou Bailing (002424.SZ) also received an administrative penalty notice for false disclosures in its annual reports for 2019, 2020, 2021, and 2023, resulting in a name change to "ST Bailing" and a risk warning [3][4] Group 2 - Guizhou Bailing was found to have understated sales expenses from 2019 to 2021, leading to an inflated profit of 65.4726 million yuan, while in 2023, it overstated sales expenses, reducing profit by 45.9411 million yuan [4] - The Guizhou Securities Regulatory Bureau plans to impose a fine of 10 million yuan on Guizhou Bailing and issue warnings to responsible individuals, with a total fine of 15.6 million yuan for 10 individuals, including a 10-year market ban for Jiang Wei [4] - As of the latest closing, Guizhou Bailing's stock price increased by 1.81%, closing at 5.63 yuan per share, with a total market value of 7.868 billion yuan [5]

两家A股公司"戴帽"。 同日，贵州证监局对贵州百灵企业集团制药股份有限公司涉嫌定期报告财务数据存在虚假记载作出行政 处罚及市场禁入事先告知。经查，贵州百灵未以权责发生制为基础，按照收入成本费用配比原则确认当 期销售费用，导致2019年至2021年期间少计销售费用，累计虚增利润65472.60万元，2023年多计销售费 用，虚减利润45941.10万元。对贵州百灵多年财务造假，严重违反证券法律法规行为，贵州证监局依法 拟对贵州百灵责令改正，给予警告,处以1000万元罚款；拟对姜伟等10名责任人给予警告，处以罚款合 计1560万元，同时拟对姜伟采取10年证券市场禁入措施。 截至今日收盘，贵州百灵股价上涨1.81%，报收5.63元/股，总市值为78.68亿元。 截至今日收盘，福能东方股价上涨2.66%，报收5.41元/股，总市值为39.75亿元。 贵州百灵(002424.SZ)公告称，公司及相关人员收到贵州证监局的《行政处罚事先告知书》，公司披露 的2019年、2020年、2021年、2023年年报存在虚假记载。根据深圳证券交易所股票上市规则，公司股票 将被实施其他风险警示，股票简称由"贵州百灵"变更为"ST百灵" ...

截至今日收盘，贵州百灵股价上涨1.81%，报收5.63元/股，总市值为78.68亿元。 责编：叶舒筠 校对： 姚远 版权声明 证券时报各平台所有原创内容，未经书面授权，任何单位及个人不得转载。我社保留追 究相关 行 为主体 法律责任的权利。 两家A股公司"戴帽"。 12月19日，福能东方(300173.SZ)公告称，公司于2025年12月19日收到广东证监局下发的《行政处罚 事先告知书》。根据中国证监会行政处罚事先告知书载明的事实，公司披露的年度报告财务指标存在虚 假记载，但未触及第10.5.2条第一款规定情形，前述财务指标包括营业收入、利润总额、净利润、资产 负债表中的资产或者负债科目，公司股票将被实施其他风险警示。股票简称由"福能东方"变更为"ST福 能"，股票代码不变，仍为"300173"。公司股票自2025年12月22日开市起停牌1天，将于2025年12月 23日开市起复牌。 截至今日收盘， 福能东方股价上涨2.66%，报收5.41元/股，总市值为39.75亿元。 贵州百灵(002424.SZ)公告称，公司及相关人员收到贵州证监局的《行政处罚事先告知书》，公司披露 的2019年、2020年、2021年 ...

同日，苗药龙头股贵州百灵发布公告，贵州百灵及相关当事人收到贵州证监局出具的《行政处 罚事先告知书》，因贵州百灵披露的2019年至2021年及2023年年报存在虚假记载，深圳证券 交易所将对贵州百灵股票实施其他风险警示。 贵州百灵股票 自2025年12月22日开市起停牌一天，并于2025年12月23日开市复牌。 自2025年 12月23日开市起，贵州百灵股票简称由"贵州百灵" 变更为"ST百灵" ，股票代码不变，仍 为"002424"，股票交易日涨跌幅限制由10%变为5%。 截至12月19日，贵州百灵股价报5.63元，总市值79亿元，今年以来累计上涨超46%。 贵州百灵财务造假遭重罚 对此你有什么想说的？ 欢迎评论区聊聊~ （声明：文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。） 出品丨21财经客户端 21世纪经济报道 理想汽车组织架构调整，涉近千人，原零部件负责人离职 热搜第一，牛股瞬间闪崩12个点，网友：炒股用曲面屏太难受 SFC 21君荐读 记者丨曾静娇 编辑丨刘雪莹 12月19日晚间，据贵州证监局网站消息，近日，贵州证监局对贵州百灵企业集团制药股份有限 公司(以下简称"贵州百灵")涉嫌定期 ...

Core Viewpoint - Guizhou BaiLing (002424) is facing severe penalties from the China Securities Regulatory Commission (CSRC) due to violations related to financial disclosures, leading to significant fines and management repercussions [1][4][9]. Financial Misconduct - Guizhou BaiLing has been found guilty of financial misconduct over four years, with false records in annual reports leading to penalties [4]. - The company failed to adhere to the accounting standards, resulting in understated sales expenses and overstated profits for the years 2019, 2020, 2021, and 2023 [4]. - Specific figures include: - 2019: Understated sales expenses by 350.12 million, overstated profits by 350.12 million, 95.73% of reported profit [4] - 2020: Understated sales expenses by 240.81 million, overstated profits by 240.81 million, 115.35% of reported profit [4] - 2021: Understated sales expenses by 63.79 million, overstated profits by 63.79 million, 45.04% of reported profit [4] - 2023: Overstated sales expenses by 459.41 million, understated profits by 459.41 million, 93.17% of reported profit [4] Penalties and Management Accountability - The CSRC has proposed a fine of 10 million for Guizhou BaiLing and a warning for the company to rectify its practices [4]. - The former chairman, Jiang Wei, is facing a 5 million fine and a 10-year ban from the securities market due to his direct involvement in the misconduct [5]. - Other executives are also facing fines ranging from 60,000 to 3.5 million, reflecting the severity of their roles in the financial misreporting [6][7]. Stock Market Impact - Starting December 23, the company's stock will be renamed "ST BaiLing" and will face additional risk warnings due to the financial misconduct [10]. - The company has confirmed that it has not reached conditions for mandatory delisting but will be under increased scrutiny [10]. Company Operations - Despite the ongoing issues, Guizhou BaiLing has stated that its production and business activities remain normal [11]. - The company has committed to improving internal controls and governance to prevent future violations [11]. Recent Performance - For the first three quarters of 2025, Guizhou BaiLing reported a revenue of 2.102 billion, a decrease of 24.28% year-on-year, and a net profit of 56.81 million, down 35.60% year-on-year [13].

近日，中国证券监督管理委员会贵州监管局(以下简称贵州证监局)对贵州百灵企业集团制药股份有限公 司(以下简称贵州百灵)涉嫌定期报告财务数据存在虚假记载作出行政处罚及市场禁入事先告知。 财务造假是严重破坏市场"三公"原则，侵害投资者合法权益的毒瘤。贵州证监局将坚决贯彻证监会党委 的各项决策部署，着力提升监管执法的有效性和震慑力，坚持对财务造假"零容忍"打击的鲜明立场，聚 焦打大、打恶、打重点，紧盯实控人、控股股东、董事、高管等"关键少数"和中介机构"看门人"，严格 执法、秉公执法，坚决做到监管"长牙带刺"、有棱有角，以有力监管执法护航贵州资本市场行稳致远。 来源｜证监会网站 经查，贵州百灵未以权责发生制为基础，按照收入成本费用配比原则确认当期销售费用，导致2019年至 2021年期间少计销售费用，累计虚增利润65472.60万元，2023年多计销售费用，虚减利润45941.10万 元。对贵州百灵多年财务造假，严重违反证券法律法规行为，贵州证监局依法拟对贵州百灵责令改正， 给予警告，处以1000万元罚款;拟对姜伟等10名责任人给予警告，处以罚款合计1560万元，同时拟对姜 伟采取10年证券市场禁入措施。 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) imposed a fine of 3 million yuan on Qingdao Damo Securities Investment Co., Ltd. and revoked its securities investment consulting business license due to serious violations of regulations [1][9]. Group 1: Violations and Penalties - Damo Investment failed to properly maintain and destroyed relevant documents and materials, leading to significant omissions in reports submitted to the securities regulatory authority [4][7]. - The company reported a total of 485 million yuan in unreported operating income from September 2022 to August 2024, indicating severe violations with a large number of affected clients [5][7]. - Four responsible individuals received penalties, including warnings and fines ranging from 30,000 to 600,000 yuan, highlighting the accountability of management and operational staff [9][10]. Group 2: Regulatory Context - The revocation of the business license is considered a "top-tier penalty" for licensed securities investment consulting firms, which is more severe than a monetary fine [10]. - Recent regulatory actions indicate a tightening stance on securities investment consulting firms, as evidenced by similar penalties imposed on other firms like Beijing Zhongfang Xinfeng Investment Management Consulting Co., Ltd. [11].